Laboratory Industry Doesn’t Forget COVID-19, But Shifts Focus to Other Health Conditions at AACC 2022 in Chicago

/by Daniel Granderson

Urgent healthcare problems were addressed at the 2022 American Association for Clinical Chemistry (AACC) meeting of lab professionals and IVD vendors in Chicago.  Kidney disease, drugs of abuse, hematology and liver disease were among areas of new product development and studies. Medical market research firm Kalorama Information (www.kaloramainformation.com) notes there were 331 contract manufacturers, 42 […]

Read more

At-Home Diagnostic Testing: COVID-19 Has Consumers More Comfortable with Tests for Infectious Diseases

/by Daniel Granderson

The global at-home in vitro diagnostics (IVD) testing market had sales of $20.5 billion in 2021, up more than 35% from the previous year, largely due to increased testing in the infectious disease segment. Glucose testing and COVID-19 testing accounted for the majority of sales, according to leading medical market researcher Kalorama Information in the […]

Read more

106 Billion IVD Procedures and Counting

/by Daniel Granderson

“Medical market researcher Kalorama Information forecasts exponential growth in both in vitro diagnostics (IVD) procedures and sales between 2021 and 2026.”   The global in vitro diagnostics (IVD) procedures market continues to grow off momentum originating at the height of the pandemic and lingering on today. There are currently 106,624 million (106 billion) in vitro […]

Read more

COVID-19 and 6 Other Trends Impacting the In Vitro Diagnostics (IVD) Market

/by Daniel Granderson

  “In many ways, the IVD testing market is center stage for the fight against the coronavirus…The COVID-19 market continues to play a major role in the growth of the IVD market with tests for the virus representing 27% of sales in 2021.” – Kalorama Information   Make no mistake, the in vitro diagnostics (IVD) […]

Read more

Infographic: Blood Screening & Blood Transfusions

/by Daniel Granderson

“The United States is the biggest user of blood transfusions—approximately 5 million people in the U.S. receive blood and blood components through 10.9 million transfusions per year.” – Kalorama Information   The global $2.5 billion blood screening market is evolving on many levels, and despite it’s maturity the industry is poised for growth through 2026 […]

Read more

School-Based Telehealth Makes the Grade in $54.5 Billion Global Remote Patient Monitoring Market

/by Daniel Granderson

  As millions of children in America return to school, the disruptive presence and impact of COVID-19 lingers. One notable result of the pandemic was the healthcare industry’s increased reliance on remote patient monitoring and telehealth—aka telemedicine. The use of telehealth in the classroom is poised to play an important role in the present and […]

Read more

What’s Trending in Library Preparation and Target Enrichment for Next-Generation Sequencing (NGS)

/by Daniel Granderson

  The next-generation sequencing (NGS) library preparation and target enrichment market is estimated to have global sales of $1.2 billion in 2021, and is forecast to surpass $3.0 billion in 2026. This amounts to a compound annual growth rate (CAGR) of 19.9%, according to leading medical market research publisher Kalorama Information in the recent report […]

Read more

U.S. Out-Of-Pocket Healthcare Spending Swells to $491 Billion, Up 10%

/by Daniel Granderson

By Daniel Granderson   In 2021, total U.S. out-of-pocket healthcare spending by consumers reached an estimated $491.6 billion, up about 10% from the prior year with continued annual growth of 9.9% expected through 2026. This will result in almost $800 billion of consumer out-of-pocket healthcare spending in 2026, reports leading medical market research publisher Kalorama […]

Read more

$41 Billion U.S. In Vitro Diagnostics (IVD) Market to Grow 5% Through 2025

/by Daniel Granderson

By Daniel Granderson   The IVD market’s growth in key segments in the U.S. has been accelerated due to the COVID-19 pandemic and the need for testing for the coronavirus. The United States is the largest healthcare market in the world with high privatization of payments relative to other major developed countries. The U.S. healthcare […]

Read more

COVID-19 Testing Increases Demand in $150 Billion Clinical Laboratory Services Market, Future Growth Linked to Global Economies

/by Daniel Granderson

  The global market for clinical laboratory services grew to an estimated $150.4 billion during 2020, with COVID-19 testing demand increasing the market by more than $26 billion over the year. These findings are according to insights featured in Clinical Laboratory Services Market, 6th Edition, a new report by leading medical market research publisher Kalorama […]

Read more